Previous 10 | Next 10 |
Are These On Your Penny Stocks Watch List In 2020? I’m pretty sure that most people don’t think about penny stocks and analyst ratings at first. From what I’m sure many of you initially experienced, penny stocks have been known for volatile trading of “start-up...
Genprex (NASDAQ: GNPX) , a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of Shannon Inman as Vice President of Global Clinical Operations. According to the update, Inman will lead in...
Proven executive with clinical operations expertise to guide Company’s clinical programs with gene therapies Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX ), a clinical-stage gene therapy company developing potentially life-changing tech...
Genprex (NASDAQ: GNPX) , a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of three new members to its Board of Directors. The new appointments, which include Brent Longnecker, CEO of ...
Genprex (NASDAQ: GNPX ) appoints three new members to its Board of Directors. The new Board members include Brent Longnecker, CEO of Longnecker & Associates, Jose A. Moreno Toscano, CEO of LFB USA Inc, and William R. (“Will”) Wilson, Jr., Chairman, President and CEO ...
Board additions will enhance Company’s ability to execute on key corporate initiatives Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX ), a clinical-stage gene therapy company developing potentially life-changing technologies for patients ...
Genprex (NASDAQ: GNPX) , a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of Catherine M. Vaczy as executive vice president and chief strategy officer and Michael T. Redman as executi...
BioNTech SE (NASDAQ: BNTX ) -16% . More news on: BioNTech SE, Mesoblast Limited, InterContinental Hotels Group PLC, Stocks on the move, , Read more ...
Sasol (NYSE: SSL ) -36% . More news on: Sasol Limited, Sibanye Stillwater Limited, Caesars Entertainment Corporation, Stocks on the move, , Read more ...
Quorum Health (NYSE: QHC ) -53% . More news on: Quorum Health Corporation, Sasol Limited, Enable Midstream Partners, LP, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting PR Newswire Compelling Data Validates the Potential...
Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer PR Newswire Multiple clinical trial sites to be opened under collaboration with large network of community-based oncol...
Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company today announced that its research collaborators have published positive preclinical data for the NPRL2 tumor suppressor gene, utilizin...